Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print September 24, 2001, 10.1148/radiol.2212010142
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2212010142v1
221/2/371    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, V. S.
Right arrow Articles by Weinreb, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, V. S.
Right arrow Articles by Weinreb, J. C.
(Radiology. 2001;221:371-379.)
© RSNA, 2001


Genitourinary Imaging

MR Renography with Low-Dose Gadopentetate Dimeglumine: Feasibility1

Vivian S. Lee, MD, PhD, Henry Rusinek, PhD, Glyn Johnson, PhD, Neil M. Rofsky, MD, Glenn A. Krinsky, MD and Jeffrey C. Weinreb, MD

1 From the Department of Radiology-MRI, New York University, 530 First Ave, HCC Basement, New York, NY 10016. From the 1999 RSNA scientific assembly. Received December 14, 2000; revision requested February 4, 2001; revision received February 21; accepted March 19. Supported in part by a 1998 RSNA Research and Education Fund Seed Grant, National Institutes of Health grant K23-DK02814, and a Society of Computed Body Tomography/Magnetic Resonance Lauterbur Award. Address correspondence to V.S.L. (e-mail: lee@mri.med.nyu.edu).

PURPOSE: To develop a low-dose magnetic resonance (MR) renographic method performed with and without an angiotensin converting enzyme (ACE) inhibitor and in conjunction with gadolinium-enhanced MR angiography in patients with suspected renovascular disease.

MATERIALS AND METHODS: Thirty-two patients underwent MR renography (turbo fast low-angle shot sequence: repetition time, 5 msec; echo time, 2.3 msec; flip angle, 15°; one coronal image acquired every 2 seconds for 4 minutes) following intravenous injection of 2 mL of gadopentetate dimeglumine, which was repeated following intravenous injection of an ACE inhibitor. Contrast material–enhanced MR angiography was also performed. On the basis of renographic findings, renal cortex and renal medulla enhancement curves and normalized enhancement ratios were analyzed.

RESULTS: The cortex and medulla showed an early transient period of enhancement within 20 seconds (vascular phase). During 1–2 minutes, a second, gradual increase in medullary enhancement, reflecting transit of filtered contrast material, was observed that was significantly greater in patients with a serum creatinine level less than 2 mg/dL (177 µmol/L) than in those with a level of 2 mg/dL or greater (P < .01). After injection of the ACE inhibitor, patients with elevated creatinine levels showed low renal medullary enhancement regardless of the presence of renal artery stenosis (RAS). However, in patients with creatinine less than 2 mg/dL, medullary enhancement ratios after injection of the ACE inhibitor were consistently lower in patients with RAS of 50% or greater than in those without stenosis (P = .02 to .08).

CONCLUSION: Low-dose MR renography can be performed in the clinical setting before and after injection of an ACE inhibitor, and its potential use for evaluating decreased renal function as a consequence of RAS is promising.

Index terms: Kidney, function, 81.12143, 81.12144 • Magnetic resonance (MR), vascular studies, 961.12942, 961.12943 • Renal arteries, stenosis or obstruction, 961.72




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
V. S. Lee, H. Rusinek, L. Bokacheva, A. J. Huang, N. Oesingmann, Q. Chen, M. Kaur, K. Prince, T. Song, E. L. Kramer, et al.
Renal function measurements from MR renography and a simplified multicompartmental model
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1548 - F1559.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
S J Gandy, K Armoogum, R S Nicholas, T B McLeay, and J G Houston
A clinical MRI investigation of the relationship between kidney volume measurements and renal function in patients with renovascular disease
Br. J. Radiol., January 1, 2007; 80(949): 12 - 20.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
H. J. Michaely, S. O. Schoenberg, N. Oesingmann, C. Ittrich, C. Buhlig, D. Friedrich, A. Struwe, J. Rieger, C. Reininger, W. Samtleben, et al.
Renal Artery Stenosis: Functional Assessment with Dynamic MR Perfusion Measurements--Feasibility Study
Radiology, February 1, 2006; 238(2): 586 - 596.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
H. S. Teh, E. S. Ang, W. C. Wong, S. B. Tan, A. G. S. Tan, S. M. Chng, M. B. K. Lin, and J. S. K. Goh
MR Renography Using a Dynamic Gradient-Echo Sequence and Low-Dose Gadopentetate Dimeglumine as an Alternative to Radionuclide Renography
Am. J. Roentgenol., August 1, 2003; 181(2): 441 - 450.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
V. S. Lee, H. Rusinek, M. E. Noz, P. Lee, M. Raghavan, and E. L. Kramer
Dynamic Three-dimensional MR Renography for the Measurement of Single Kidney Function: Initial Experience
Radiology, April 1, 2003; 227(1): 289 - 294.
[Abstract] [Full Text] [PDF]